Delaware Chapter of the American College of CardiologyOur purpose is to contribute to the prevention of cardiovascular diseases, to ensure optimal quality of care for individuals with such diseases, and to foster the highest professional ethical standards. Please let us know what information you want to see here. Feel free to contact us with your ideas, needs and comments. |
|
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Latest in Cardiology from ACC.org
- FDA Update: Agency Warns of Transcatheter MV Delivery System IssueThe U.S. Food and Drug Administration (FDA) has issued an Early Alert, warning that Edwards Lifesciences is recommending certain delivery systems used for the SAPIEN M3 transcatheter mitral valve (MV) replacement be removed from use.
- Pullback Pressure Gradient: Unlocking the Functional Map of CADCoronary angiography has long served as the anatomical cornerstone for guiding PCI. Yet, the visual severity of a stenosis does not always reflect its physiological significance.
- Interventional Post-ACS Antithrombotic Trials at ESC Congress 2026Four late-breaking trials, presented at ESC Congress 2026 focused on post-acute coronary syndrome (ACS) antithrombotic therapy.
- Sports Cardiology Research and Guideline Highlights: Early 2026The 2026 ESC/ACC clinical consensus statement on Masters Athletes With Abnormal Cardiovascular Findings is guided by a clinical consensus statement outlining expert recommendations for the diagnostic assessment, management, and risk stratification of cardiac abnormalities in masters athletes (MAs).
- Structural Heart Disease Trials Featured at ESC Congress 2026Four late-breaking trials presented at ESC Congress 2026 offer new insights into the management of structural heart disease and heart failure (HF).



